Skip to content

Research at St Andrews

The impact of cancer on subsequent chance of pregnancy: a population-based analysis

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Richard A Anderson, David H Brewster, Rachael Wood, Sian Nowell, Colin Fischbacher, Thomas William Kelsey, W Hamish B Wallace

School/Research organisations

Abstract

STUDY QUESTION
What is the impact of cancer in females aged ≤39 years on subsequent chance of pregnancy?

SUMMARY ANSWER
Cancer survivors achieved fewer pregnancies across all cancer types, and the chance of achieving a first pregnancy was also lower.

WHAT IS KNOWN ALREADY
The diagnosis and treatment of cancer in young females may be associated with reduced fertility but the true pregnancy deficit in a population is unknown.

STUDY DESIGN, SIZE, DURATION
We performed a retrospective cohort study relating first incident cancer diagnosed between 1981 and 2012 to subsequent pregnancy in all female patients in Scotland aged 39 years or less at cancer diagnosis (n = 23 201). Pregnancies were included up to end of 2014. Females from the exposed group not pregnant before cancer diagnosis (n = 10 271) were compared with general population controls matched for age, deprivation quintile and year of diagnosis.

PARTICIPANTS/MATERIALS, SETTING, METHODS
Scottish Cancer Registry records were linked to hospital discharge records to calculate standardized incidence ratios (SIR) for pregnancy, standardized for age and year of diagnosis. Linkage to death records was also performed. We also selected women from the exposed group who had not been pregnant prior to their cancer diagnosis who were compared with a matched control group from the general population. Additional analyses were performed for breast cancer, Hodgkin lymphoma, leukaemia, cervical cancer and brain/CNS cancers.

MAIN RESULTS AND THE ROLE OF CHANCE
Cancer survivors achieved fewer pregnancies: SIR 0.62 (95% CI: 0.60, 0.63). Reduced SIR was observed for all cancer types. The chance of achieving a first pregnancy was also lower, adjusted hazard ratio = 0.57 (95% CI: 0.53, 0.61) for women >5 years after diagnosis, with marked reductions in women with breast, cervical and brain/CNS tumours, and leukaemia. The effect was reduced with more recent treatment period overall and in cervical cancer, breast cancer and Hodgkin lymphoma, but was unchanged for leukaemia or brain/CNS cancers. The proportion of pregnancies that ended in termination was lower after a cancer diagnosis, and the proportion ending in live birth was higher (78.7 vs 75.6%, CI of difference: 1.1, 5.0).

LIMITATIONS, REASONS FOR CAUTION
Details of treatments received were not available, so the impact of specific treatment regimens on fertility could not be assessed. Limited duration of follow-up was available for women diagnosed in the most recent time period.
WIDER IMPLICATIONS OF THE FINDINGSThis analysis provides population-based quantification by cancer type of the effect of cancer and its treatment on subsequent pregnancy across the reproductive age range, and how this has changed in recent decades. The demonstration of a reduced chance of pregnancy across all cancer types and the changing impact in some but not other common cancers highlights the need for appropriate fertility counselling of all females of reproductive age at diagnosis.
STUDY FUNDING/COMPETING INTEREST(S)
This study was funded by NHS Lothian Cancer and Leukaemia Endowments Fund. Part of this work was undertaken in the MRC Centre for Reproductive Health which is funded by the MRC Centre grant MR/N022556/1. RAA has participated in Advisory Boards and/or received speaker’s fees from Beckman Coulter, IBSA, Merck and Roche Diagnostics. He has received research support from Roche Diagnostics, Ansh labs and Ferring. The other authors have no conflicts to declare.
Close

Details

Original languageEnglish
Pages (from-to)1281-1290
Number of pages10
JournalHuman Reproduction
Volume33
Issue number7
Early online date15 Jun 2018
DOIs
StatePublished - Jul 2018

    Research areas

  • Epidemiology, Fertility preservation, Pregnancy, Cancer, Cancer survivor, Pregnancy outcome

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Cryopreservation of ovarian tissue may be considered in young girls with galactosemia

    Mamsen, L. S., Kelsey, T. W., Ernst, E., Macklon, K. T., Lund, A. M. & Andersen, C. Y. 26 May 2018 In : Journal of Assisted Reproduction and Genetics. First Online

    Research output: Contribution to journalArticle

  2. Follicle size on day of trigger most likely to yield a mature oocyte

    Abbara, A., Vuong, L. N., Ho, V. N. A., Clarke, S. A., Jeffers, L., Comninos, A. N., Salim, R., Ho, T. M., Kelsey, T. W., Trew, G. H., Humaiden, P. & Dhillo, W. S. 25 Apr 2018 In : Frontiers in Endocrinology. 9, 11 p., 193

    Research output: Contribution to journalArticle

  3. Clinical parameters of ovarian hyperstimulation syndrome (OHSS) following different triggers of oocyte maturation in IVF treatment

    Abbara, A., Islam, R., Clarke, S. A., Jeffers, L., Christopoulos, G., Comninos, A. N., Salim, R., Lavery, S. A., Vuong, T. N. L., Humaidan, P., Kelsey, T. W., Trew, G. H. & Dhillo, W. S. 6 Mar 2018 In : Clinical Endocrinology. Early View, 8 p.

    Research output: Contribution to journalArticle

  4. Concentration of perfluorinated compounds and cotinine in human foetal organs, placenta, and maternal plasma

    Mamsen, L. S., Jönsson, B. A. G., Lindh, C. H., Olesen, R. H., Larsen, A., Ernst, E., Kelsey, T. W. & Andersen, C. Y. 15 Oct 2017 In : Science of the Total Environment. 596-597, p. 97-105 9 p.

    Research output: Contribution to journalArticle

  5. Follicle Stimulating Hormone is an accurate predictor of azoospermia in childhood cancer survivors

    Kelsey, T. W., McConville, L., Edgar, A. B., Ungurianu, A. I., Mitchell, R. T., Anderson, R. A. & Wallace, W. H. B. 20 Jul 2017 In : PLoS One. 12, 7, 11 p., e0181377

    Research output: Contribution to journalArticle

Related by journal

  1. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary

    McLaughlin, M., Kelsey, T. W., Wallace, W. H. B., Anderson, R. A. & Telfer, E. E. Jan 2017 In : Human Reproduction. 32, 1, p. 165-174

    Research output: Contribution to journalArticle

  2. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations

    Phillips, K-A., Collins, I. M., Milne, R. L., McLachlan, S. A., Friedlander, M., Hickey, M., Stern, C., Hopper, J. L., Fisher, R., Kannemeyer, G., Picken, S., Smith, C. D., Kelsey, T. W. & Anderson, R. A. May 2016 In : Human Reproduction. 31, 5, p. 1126-1132 7 p.

    Research output: Contribution to journalArticle

  3. The relation between variation in size of the primordial follicle pool and menopause: a cohort comparison for observed and predicted distribution of age at menopause

    Depmann, M., Faddy, M. J., van der Schouw, Y. T., Broer, S. L., Kelsey, T. W., Nelson, S. M. & Broekmans, F. J. M. Jun 2015 In : Human Reproduction. 30, p. 408-408 1 p.

    Research output: Contribution to journalAbstract

  4. Can anti-Mullerian hormone (AMH) predict the diagnosis of polycystic ovary syndrome (PCOS) - a systematic review and meta-analysis

    Iliodromiti, S., Kelsey, T., Anderson, R. & Nelson, S. Jun 2013 In : Human Reproduction. 28, Suppl. 1, p. i332-i332

    Research output: Contribution to journalAbstract

ID: 253097930